Literature DB >> 31328310

Chemical Synthesis of Oligoribonucleotide (ASL of tRNALys T. brucei) Containing a Recently Discovered Cyclic Form of 2-Methylthio-N6 -threonylcarbamoyladenosine (ms2 ct6 A).

Katarzyna Debiec1, Michal Matuszewski1, Karolina Podskoczyj1, Grazyna Leszczynska1, Elzbieta Sochacka1.   

Abstract

The synthesis of the protected form of 2-methylthio-N6 -threonylcarbamoyl adenosine (ms2 t6 A) was developed starting from adenosine or guanosine by using the optimized carbamate method and, for the first time, an isocyanate route. The hypermodified nucleoside was subsequently transformed into the protected ms2 t6 A-phosphoramidite monomer and used in a large-scale synthesis of the precursor 17nt ms2 t6 A-oligonucleotide (the anticodon stem and loop fragment of tRNALys from T. brucei). Finally, stereochemically secure ms2 t6 Ams2 ct6 A cyclization at the oligonucleotide level efficiently afforded a tRNA fragment bearing the ms2 ct6 A unit. The applied post-synthetic approach provides two sequentially homologous ms2 t6 A- and ms2 ct6 A-oligonucleotides that are suitable for further comparative structure-activity relationship studies.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  RNA structures; nucleosides; oligoribonucleotides; postsynthetic modifications; tRNA

Mesh:

Substances:

Year:  2019        PMID: 31328310     DOI: 10.1002/chem.201902411

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

Review 1.  Synthesis of Nucleobase-Modified RNA Oligonucleotides by Post-Synthetic Approach.

Authors:  Karolina Bartosik; Katarzyna Debiec; Anna Czarnecka; Elzbieta Sochacka; Grazyna Leszczynska
Journal:  Molecules       Date:  2020-07-23       Impact factor: 4.411

2.  Efficient access to 3'-O-phosphoramidite derivatives of tRNA related N 6-threonylcarbamoyladenosine (t6A) and 2-methylthio-N 6-threonylcarbamoyladenosine (ms2t6A).

Authors:  Katarzyna Debiec; Elzbieta Sochacka
Journal:  RSC Adv       Date:  2021-01-07       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.